Haloperidol Tablets

This product belongs to the butyrophenone antipsychotic drug. Its antipsychotic effect is related to its ability to block dopamine receptors in the brain and promote the conversion of dopamine in the brain. It has a good effect on resisting hallucinations and delusions and excitement and agitation, has a strong effect in blocking extrapyramidal dopamine, and also has a strong antiemetic effect, but its sedative effect and blocking effects on beta-adrenergic receptors and cholinergic receptors are weak.

The main ingredient of this product is haloperidol, and its chemical name is: 1-(4-fluorophenyl)-4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1-butanone.

This product is a sugar-coated tablet, which appears white after removing the sugar coating.

It is used for acute and chronic schizophrenia, mania, Tourette syndrome. It is effective in controlling excitement, agitation, hostility and aggressive behavior. Because this product has fewer adverse reactions to the cardiovascular system, it can also be used for organic brain disorders and senile mental disorders.

For the treatment of schizophrenia, start with a small oral dose, 2 to 4 mg once, 2 to 3 times a day. Gradually increase to the usual dose of 10 to 40 mg per day, and maintain a dose of 4 to 20 mg per day. For the treatment of Tourette syndrome, 1 to 2 mg once, 2 to 3 times a day.

1. Extrapyramidal reactions are more severe and common. Acute dystonia is more likely to occur in children and adolescents, with obvious torsion spasms, dysphagia, akathisia and Parkinson's disease. 2. Long-term and excessive use may cause tardive dyskinesia. 3. Dry mouth, blurred vision, fatigue, constipation, sweating, etc. may occur. 4. It may cause an increase in plasma prolactin concentration. Possible related symptoms include: galactorrhea, gynecomastia, menstrual disorders, and amenorrhea. 5. A small number of patients may experience depressive reactions. 6. Allergic rashes, neutropenia and malignant syndrome are occasionally seen.

Patients with basal ganglia lesions, Parkinson's disease, Parkinson's syndrome, severe central nervous system depression, bone marrow suppression, glaucoma, myasthenia gravis and allergic to this product.

Precautions for children: Refer to the adult dose and reduce the dose as appropriate. Precautions for pregnancy and lactation: Pregnant women should use with caution. Lactating women should stop breastfeeding while using this product. Precautions for the elderly: Start with a small dose and increase the dose slowly to avoid extrapyramidal reactions and tardive dyskinesia.

1. When this product is used in combination with ethanol or other central nervous system depressants, the central nervous system depressant effect is enhanced. 2. When this product is used in combination with amphetamine, the latter's effect can be reduced. 3. When this product is used in combination with barbiturates or other anticonvulsants: it can change the form of epileptic seizures; it cannot enhance the efficacy of anticonvulsants. 4. When this product is used in combination with antihypertensive drugs, severe hypotension can occur. 5. When this product is used in combination with anticholinergic drugs, it may increase intraocular pressure. 6. When this product is used in combination with adrenaline, the activity of the receptors is dominant due to the blocking of receptors, which can lead to a decrease in blood pressure. 7. When this product is used in combination with lithium salts, it is necessary to observe neurotoxicity and brain damage. 8. When this product is used in combination with methyldopa, it can produce impaired consciousness, slow thinking, and disorientation. 9. When this product is used in combination with carbamazepine, the blood concentration of this product can be reduced and the effect can be weakened. 10. Drinking tea or coffee can reduce the absorption of this product and reduce its efficacy.

Keep away from light and store in sealed container.

4mg

36 months.

Baishan Changbaishan Pharmaceutical Co., Ltd.

• Founded in:

  2001-03-30

• Address:

  No. 43, West Chang'an Road, Minzhu Street, Jiaohe City, Jilin Province

• Tax NO.:

  9122020172313976XT

• Registered Funds:

  67.119258 million yuan

• Website:

  Log in to view

• Email:

  Log in to view